Maternal exposure to heparin products and risk of birth defects in the National Birth Defects Prevention Study-Reference-Cited by-同舟云学术

Maternal exposure to heparin products and risk of birth defects in the National Birth Defects Prevention Study

Published:2022-08-14 Issue:2 Volume:115 Page:133-144
ISSN:2472-1727
Container-title:Birth Defects Research
language:en
Short-container-title:Birth Defects Research

Author:

Howley Meredith M.¹^ORCID,Fisher Sarah C.¹^ORCID,Van Zutphen Alissa R.¹²,Papadopoulos Eleni A.¹^ORCID,Patel Jenil³⁴^ORCID,Lin Angela E.⁵,Browne Marilyn L.¹²,

Affiliation:

1. Birth Defects Registry New York State Department of Health Albany New York USA

2. Department of Epidemiology and Biostatistics School of Public Health, University at Albany Rensselaer New York USA

3. Department of Epidemiology, Human Genetics and Environmental Sciences University of Texas Health Science Center at Houston (UTHealth) School of Public Health Dallas Texas USA

4. Arkansas Center for Birth Defects Research and Prevention Fay W. Boozman College of Public Health, University of Arkansas for Medical Science Little Rock Arkansas USA

5. Medical Genetics Unit, Department of Pediatrics MassGeneral Hospital for Children Boston Massachusetts USA

Funder

Centers for Disease Control and Prevention

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Developmental Biology,Toxicology,Embryology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bdr2.2074

Reference42 articles.

1. Anticoagulation During Pregnancy

2. A Low Molecular Weight Heparin Alters the Fetal Coagulation System in the Pregnant Sheep

3. Low-molecular-weight heparin for thrombophilia in pregnant women

4. Women's values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview study

5. The Role of Thrombophilia in Pregnancy